Inception Return
(11/22/2007)
|
4.64 %
|
|
YTD Return
|
9.47 %
|
|
NAVPS
(11/21/2019)
|
$8.31
|
|
Change
|
($0.04) / -0.48 %
|
|
|
Growth of $10,000
(As of October 31, 2019)
|
|
MER
|
2.15 %
|
|
Assets ($mil)
|
$90.86
|
|
Rank (1Yr)
|
352/461
|
|
Std Dev (3Yr)
|
8.97 %
|
|
Volatility Ranking (3Yr)
|
6/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Back Fee Only
|
|
Max Front End
|
-
|
|
Max Back End
|
6.00 %
|
|
Sales Status
|
Open
|
|
|
Objective
The fund's investment objective is to provide long term capital growth. This fund invests directly, or through investments in securities of other mutual funds, in a portfolio mainly composed of equities of foreign companies located outside North America and in American Depository Receipts (ADR) traded on recognized stock exchanges.
|
Management Co.
National Bank Investments Inc.
Managers
Len Ioffe, Osman Ali
|
|
Asset Allocation
(As of October 31, 2019)
|
Sector Allocation
(As of October 31, 2019)
|
Geographic Allocation
(As of October 31, 2019)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Cash and Cash Equivalents | Cash and Equivalents | Cash and Cash Equivalent | Canada | 3.10% |
| Roche Holding AG - Participation | International Equity | Healthcare | Other European | 1.96% |
| Novartis AG | International Equity | Healthcare | Other European | 1.76% |
| AIA Group Ltd | International Equity | Financial Services | Asia/Pacific Rim | 1.30% |
| Total SA | International Equity | Energy | European Union | 1.20% |
| BP PLC - ADR | International Equity | Energy | European Union | 1.14% |
| Novo Nordisk A/S Cl B | International Equity | Healthcare | European Union | 1.13% |
| Diageo PLC | International Equity | Consumer Goods | European Union | 1.12% |
| Royal Dutch Shell PLC Cl A | International Equity | Energy | European Union | 1.11% |
| Bayer AG | International Equity | Healthcare | European Union | 0.97% |
Performance Data
(As of October 31, 2019)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
2.63
|
3.92
|
0.12
|
9.47
|
6.33
|
5.67
|
3.66
|
7.52
|
|
Benchmark
|
3.18
|
4.27
|
1.10
|
11.93
|
10.79
|
7.65
|
7.91
|
7.82
|
|
Quartile Ranking
|
2
|
1
|
3
|
3
|
4
|
3
|
4
|
1
|
|
Calendar Return (%)
|
2018
|
2017
|
2016
|
2015
|
2014
|
2013
|
2012
|
2011
|
2010
|
2009
|
|
Fund
|
-10.06
|
15.45
|
-2.80
|
13.37
|
0.22
|
37.37
|
10.76
|
-11.47
|
13.36
|
24.86
|
|
Benchmark
|
-6.81
|
18.38
|
-1.70
|
19.41
|
4.12
|
32.41
|
14.58
|
-10.59
|
3.24
|
14.82
|
|
Quartile Ranking
|
3
|
3
|
2
|
3
|
3
|
1
|
4
|
2
|
1
|
1
|
MSCI ESG Fund Metrics (As of October 01, 2019)
|
The MSCI ESG Quality Score measures the ability of underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors.
|
|
The percentage of the portfolio's market value exposed to companies flagged for one or more standard SRI exclusion factors (alcohol, civilian firearms, gambling, weapons, cluster bombs, landmines, nuclear power, GMOs, and tobacco).
|
The portfolio weighted average of each company’s percent of revenue generated by Sustainable Impact Solutions (goods and services that address at least one of the world’s social and environmental challenges), as defined by the United Nations Sustainable Development Goals.
|
ESG data provided by MSCI
MSCI ESG Research LLC’s (“MSCI ESG”) Fund Metrics products (the “Information”) provide environmental, social and governance data with respect to underlying securities within more than 23,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted to, nor received approval from, the US SEC or any other regulatory body. None of the Information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information.